78 related articles for article (PubMed ID: 32730778)
1. A novel taxane, difluorovinyl-ortataxel, effectively overcomes paclitaxel-resistance in breast cancer cells.
Rong D; Wang C; Zhang X; Wei Y; Zhang M; Liu D; Farhan H; Momen Ali SA; Liu Y; Taouil A; Guo W; Wang Y; Ojima I; Yang S; Wang H
Cancer Lett; 2020 Oct; 491():36-49. PubMed ID: 32730778
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.
Wang R; Zhang T; Yang Z; Jiang C; Seng J
J Cell Mol Med; 2018 Sep; 22(9):4068-4075. PubMed ID: 29971911
[TBL] [Abstract][Full Text] [Related]
3. Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway.
Lai TC; Fang CY; Jan YH; Hsieh HL; Yang YF; Liu CY; Chang PM; Hsiao M
Cell Commun Signal; 2020 Oct; 18(1):164. PubMed ID: 33087151
[TBL] [Abstract][Full Text] [Related]
4. Crocin enhances the sensitivity to paclitaxel in human breast cancer cells by reducing BIRC5 expression.
Jia Y; Yang H; Yu J; Li Z; Jia G; Ding B
Chem Biol Drug Des; 2024 Feb; 103(2):e14467. PubMed ID: 38661582
[TBL] [Abstract][Full Text] [Related]
5. Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy.
González M; Ovejero-Sánchez M; Vicente-Blázquez A; Álvarez R; Herrero AB; Medarde M; González-Sarmiento R; Peláez R
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673002
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia and Noncoding RNAs in Taxane Resistance.
Pucci P; Rescigno P; Sumanasuriya S; de Bono J; Crea F
Trends Pharmacol Sci; 2018 Aug; 39(8):695-709. PubMed ID: 29891252
[TBL] [Abstract][Full Text] [Related]
7. The effect of paclitaxel- and fisetin-loaded PBM nanoparticles on apoptosis and reversal of drug resistance gene ABCG2 in ovarian cancer.
McFadden M; Singh SK; Kinnel B; Varambally S; Singh R
J Ovarian Res; 2023 Nov; 16(1):220. PubMed ID: 37990267
[TBL] [Abstract][Full Text] [Related]
8. Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung Cancer.
Niu X; Wu T; Yin Q; Gu X; Li G; Zhou C; Ma M; Su L; Tang S; Tian Y; Yang M; Cui H
Cells; 2022 Oct; 11(19):. PubMed ID: 36231056
[TBL] [Abstract][Full Text] [Related]
9. LIN9 and NEK2 Are Core Regulators of Mitotic Fidelity That Can Be Therapeutically Targeted to Overcome Taxane Resistance.
Roberts MS; Sahni JM; Schrock MS; Piemonte KM; Weber-Bonk KL; Seachrist DD; Avril S; Anstine LJ; Singh S; Sizemore ST; Varadan V; Summers MK; Keri RA
Cancer Res; 2020 Apr; 80(8):1693-1706. PubMed ID: 32054769
[TBL] [Abstract][Full Text] [Related]
10. Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.
Cevatemre B; Bulut I; Dedeoglu B; Isiklar A; Syed H; Bayram OY; Bagci-Onder T; Acilan C
Cell Death Dis; 2024 Feb; 15(2):132. PubMed ID: 38346967
[TBL] [Abstract][Full Text] [Related]
11. TPI-287, a new taxane family member, reduces the brain metastatic colonization of breast cancer cells.
Fitzgerald DP; Emerson DL; Qian Y; Anwar T; Liewehr DJ; Steinberg SM; Silberman S; Palmieri D; Steeg PS
Mol Cancer Ther; 2012 Sep; 11(9):1959-67. PubMed ID: 22622283
[TBL] [Abstract][Full Text] [Related]
12. Novel C-seco-taxoids possessing high potency against paclitaxel-resistant cancer cell lines overexpressing class III beta-tubulin.
Pepe A; Sun L; Zanardi I; Wu X; Ferlini C; Fontana G; Bombardelli E; Ojima I
Bioorg Med Chem Lett; 2009 Jun; 19(12):3300-4. PubMed ID: 19423340
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy.
Pessina A; Bonomi A; Coccè V; Invernici G; Navone S; Cavicchini L; Sisto F; Ferrari M; Viganò L; Locatelli A; Ciusani E; Cappelletti G; Cartelli D; Arnaldo C; Parati E; Marfia G; Pallini R; Falchetti ML; Alessandri G
PLoS One; 2011; 6(12):e28321. PubMed ID: 22205945
[TBL] [Abstract][Full Text] [Related]
14. Preclinical small molecule WEHI-7326 overcomes drug resistance and elicits response in patient-derived xenograft models of human treatment-refractory tumors.
Grohmann C; Walker F; Devlin M; Luo MX; Chüeh AC; Doherty J; Vaillant F; Ho GY; Wakefield MJ; Weeden CE; Kamili A; Murray J; Po'uha ST; Weinstock J; Kane SR; Faux MC; Broekhuizen E; Zheng Y; Shield-Artin K; Kershaw NJ; Tan CW; Witchard HM; Ebert G; Charman SA; Street I; Kavallaris M; Haber M; Fletcher JI; Asselin-Labat ML; Scott CL; Visvader JE; Lindeman GJ; Watson KG; Burgess AW; Lessene G
Cell Death Dis; 2021 Mar; 12(3):268. PubMed ID: 33712556
[TBL] [Abstract][Full Text] [Related]
15. Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells.
Astarita EM; Maloney SM; Hoover CA; Berkeley BJ; VanKlompenberg MK; Nair TM; Prosperi JR
PLoS One; 2021; 16(8):e0255738. PubMed ID: 34370741
[TBL] [Abstract][Full Text] [Related]
16. The determination of changes in the expression of genes for selected specific transcriptional factors in in vitro ductal breast cancer cells under the influence of paclitaxel.
Ziaja-Sołtys M; Rzymowska J
Cell Mol Biol Lett; 2011 Dec; 16(4):610-24. PubMed ID: 21909792
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.
Alalawy AI; Sakran M; Alzuaibr FM; Alotaibi MA; El-Hefnawy ME; Hazazi AY; El-Gendy SM; Aidy EA; Effat H; Ismail DF; Hessien M
Sci Rep; 2023 Dec; 13(1):22782. PubMed ID: 38129495
[TBL] [Abstract][Full Text] [Related]
18. Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer.
Wang H; Nie C; Luo M; Bai Q; Yao Z; Lv H; Chen B; Wang J; Xu W; Wang S; Chen X
Bioorg Chem; 2024 Feb; 143():107056. PubMed ID: 38183685
[TBL] [Abstract][Full Text] [Related]
19. A ciprofloxacin derivative with four mechanisms of action overcomes paclitaxel resistance in p53-mutant and MDR1 gene-expressing type II human endometrial cancer.
Alhaj-Suliman SO; Naguib YW; Wafa EI; Saha S; Ebeid K; Meng X; Mohammed HH; Abuo-Rahma GEA; Yang S; Salem AK
Biomaterials; 2023 May; 296():122093. PubMed ID: 36965280
[TBL] [Abstract][Full Text] [Related]
20. pH-sensitive nanomedicine of novel tubulin polymerization inhibitor for lung metastatic melanoma.
Bhattarai RS; Bariwal J; Kumar V; Hao C; Deng S; Li W; Mahato RI
J Control Release; 2022 Oct; 350():569-583. PubMed ID: 36037976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
